(Q70955349)
Statements
Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group (English)
R Lin
E Roach
M Zimmerman
S Strasser
1 November 1995